What is urinary bladder adenocarcinoma?
About two percent of bladder cancers are adenocarcinomas, which are
nearly all invasive. Urinary bladder adenocarcinoma begins in the cells
of glandular structures lining body organs and spreads to the bladder.
After treatment, patients must be monitored carefully because the chance
of bladder cancer coming back is high—70 to 100 percent.
Who is most likely to have urinary bladder adenocarcinoma?
In general, bladder cancers occur more often in men and in people over
age 70. Chronic urinary or bladder infections and kidney and bladder
stones increase the risk of bladder cancer, as does cigarette smoking,
diets high in saturated fat, and exposure to workplace carcinogens.
Workers exposed to antineoplastic drugs (used in chemotherapy) or certain
types of hair, medical, or industrial dyes also can be at increased
risk. These workers include hairdressers, machinists, printers, painters,
truck drivers, and those in the rubber, chemical, textile, metal, and
leather industries.
What characterizes urinary bladder adenocarcinoma?
Bladder cancer is characterized by a lump or tumor that is formed in
the bladder, and if aggressive, grows outside the bladder. The most
common sign of urinary bladder adenocarcinoma is blood in the urine.
While not specific for cancer, you should always go see your doctor
if you find blood in your urine. Other symptoms include frequent, urgent,
or painful urination, but these are also not specific for cancer.
How does the pathologist make a diagnosis?
The pathologist can make the diagnosis based on examination of urine
or tissue samples that your primary care physician sends to the pathologist.
By looking at cells in the urine under the microscope and performing
other tests on the urine, pathologists can tell if cancer cells are
present or not. If your primary care physician removes tissue from the
bladder by performing a cystoscopy, which involves
putting a small tube (with a small camera) into your bladder, the pathologist
will examine sections from the biopsy specimens obtained
during this procedure. Larger pieces of the tumor can be removed and
sent to the pathologist when transurethral resection of the
bladder tumor (TURBT) is done. Finally, a part or all of the
bladder may be sent to the pathologist for examination if your surgeon
performs a partial or radical (complete)
cystectomy, respectively.
What else does the pathologist look for?
After making a diagnosis of cancer, one of the important things a pathologist
will do is determine the stage, or extent of the cancer
in the tissue. This finding will help determine prognosis and selection
of therapy. The stage usually ranges from 1 (best) to 4 (worst). The
pathologist will examine the tissue to see if the cancer has involved
the muscle wall of the bladder, lymphatic or blood vessels, and if it
has spread outside the bladder. If a cystectomy has been done, the pathologist
will also note the size of the cancer and whether the cancer is growing
to the edges (margins) of the tissue. These are helpful findings, along
with stage, in determining whether additional treatment is needed.
How do doctors determine what surgery or treatment
will be necessary?
The treatment plan is determined by the pathologist’s diagnosis
and stage determination, clinical tests such as radiology or x-ray studies,
and the insight of physicians participating in your care. In addition
to the pathologist, these physicians may include surgeons, radiation
oncologists, medical oncologists, radiologists, and others.
What kinds of treatments are available for urinary
bladder adenocarcinoma?
Urinary bladder adenocarcinoma is treated through one or more of the
following: surgery, radiation therapy, immunotherapy, and chemotherapy.
It’s important to learn as much as you can about your treatment
options and to make the decision that’s right for you.
The most common treatment for urinary bladder adenocarcinoma is surgery, which can remove the cancerous tumor from the body. Surgery is generally recommended for individuals in the first three stages of cancer, sometimes in combination with other treatments. For small tumors, a transurethral resection or partial/segmental cystectomy is performed to remove the cancerous tissue from the bladder. If the tumor is large, a radical cystectomy (removal of the bladder) may be recommended. In these cases, surgeons will form a continent urinary reservoir, a neobladder, or an ileal conduit to take the place of the bladder. Depending on the method used, an external urine-collecting bag may or may not be necessary.
Radiation therapy—pinpointed high-energy beams—can be used after surgery to destroy cancer cells that remain. This treatment is also used to relieve the symptoms of advanced bladder cancer
Physicians use immunotherapy therapy in cases of small, superficial tumors. This treatment enhances the immune system’s ability to fight the cancer.
If your cancer has spread beyond your bladder—or if there is a chance that it has—chemotherapy will likely be recommended. This treatment delivers drugs throughout the body, slows the cancer’s progression, and reduces pain.
Clinical trials of new treatments for urinary bladder adenocarcinoma may be found at www.cancer.gov/clinicaltrials. These treatments are highly experimental in nature but may be a potential option for advanced cancers.
For more information, visit the National Cancer Institute, American Cancer Society, or Cancer.Net websites. Type urinary bladder adenocarcinomas or bladder cancer into the search box.
What kinds of questions should I ask my doctors?
Ask any question you want. There are no questions you should be reluctant
to ask. Here are a few to consider:
DEFINITION OF TERMS
Urinary Bladder: A sac located in the pelvic area where urine is collected and discharged
Adenocarcinoma: A type of cancerous, or malignant, tumor originating in a glandular structure
Malignant: Cancerous and capable of spreading
Invasive, Infiltrating: Capable of spreading to other parts of the breast or body
Pathologist: A physician who examines tissues and fluids to diagnose disease in order to assist in making treatment decisions.
Lymphatic: Relating to lymph glands or their channels
This information was developed by the College of American Pathologists’ Public Affairs Committee in conjunction with the College’s Cancer Committee and Council on Scientific Affairs. The College is providing this information to help you better understand your health. Ultimately any decisions you make about your health, however, should be between you and your doctor.
Copyright 2012 | Browser Requirements | Contact | FAQ | Glossary of Terms